In its weekly update today, the US Centers for Disease Control and Prevention (CDC) reported 40 more measles cases today, ...

Shionogi will pay BioVersys $6.3 million for developing BV500, BioVersys's drug candidate for non-tuberculous mycobacteria.

Relative to before the pandemic, the number of vaccinated participants fell 10% among children and 4% in adults in pandemic ...

Compared with flu vaccine recipients, those given the RSV or shingles vaccine had 18% to 37% lower odds of receiving a ...

Livestock manure around the globe is packed with antibiotic resistance genes (ARGs) that could threaten human health, ...

Used in very low amounts, thimerosal has been used since the 1930s to prevent contamination in multidose vaccine vials, and ...

In the wake of this week's meeting of a newly reconstituted federal vaccine advisory board, public health, medical, and ...

New research suggests that a class of antibiotics commonly used in poultry and other food-producing animals, but not in ...

Cambodia's health ministry yesterday reported two more human H5N1 avian flu cases, part of a spike in cases in June, with six ...

Recent mosquito-borne illness patterns in Europe reflect the growing geographic spread and public health impact of the ...

The World Health Organization (WHO) Technical Advisory Group on Virus Evolution (TAG-VE) on June 25 added the XFG to its SARS ...

USAID, the world's largest funding agency for humanitarian and development, is estimated to have helped avert more than 91 ...